Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company dedicated to advancing the treatment of brain diseases. With a focus on developing better therapies, Chase Therapeutics pioneers the discovery and development of pharmaceuticals that are best in class or first to market. Driven by the goal of preventing and curing brain dysfunction, Chase Therapeutics is committed to rapidly translating breakthroughs in neurosciences research.

Their drug development pipeline holds promising examples of their unique approach to products targeting brain diseases. The company's dedication to improving the lives of those with neuropsychiatric diseases is evident in their mission. Chase Therapeutics aims to provide effective treatments that enhance the overall well-being of patients.

For inquiries or further information, you can reach out to Chase Therapeutics at their Washington D. C. Alternatively, you can contact them via phone at (202) 568-8831 or email at tchase@chasetherapeutics.

com. Chase Therapeutics: Pioneering better treatments for brain diseases